Cargando…

Higher persistence with valsartan compared with enalapril in daily practice

OBJECTIVE: To compare persistence with valsartan and enalapril in daily practice. METHODS: The PHARMO Record Linkage System includes various data registries including drug dispensing and hospitalizations for ≥2 million subjects in the Netherlands. Patients newly treated with valsartan or enalapril i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Siiskonen, Satu J, Breekveldt-Postma, Nancy S, Vincze, Gábor, Khan, Zeba M, Erkens, Joëlle A, Herings, Ron MC
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350122/ https://www.ncbi.nlm.nih.gov/pubmed/18200822

Ejemplares similares

Comparison of Sacubitril/Valsartan Versus Enalapril in the Management of Heart Failure
por: Bano, Shehar, et al.
Publicado: (2021)

Cost-utility analysis of valsartan, enalapril, and candesartan in patients with heart failure in Iran
por: Ravangard, Ramin, et al.
Publicado: (2023)

Cost-Effectiveness Analysis of Sacubitril/Valsartan Compared to Enalapril for Heart Failure Patients in Indonesia
por: Zakiyah, Neily, et al.
Publicado: (2021)

Reduced loop diuretic use in patients taking sacubitril/valsartan compared with enalapril: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2019)

Safety and efficacy of ARNI (valsartan/sacubitril) vs ACEI (enalapril) in acute heart failure – A prospective observational study
por: Bhat, Tahir Saleem, et al.
Publicado: (2022)

Sacubitril-Valsartan Compared With Enalapril for the Treatment of Heart Failure: A Decision-Analytic Markov Model Simulation in China
por: Wu, Yue, et al.
Publicado: (2020)

Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
por: Morrow, David A, et al.
Publicado: (2019)

Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Effect of sacubitril/valsartan vs. enalapril on changes in heart failure therapies over time: the PARADIGM‐HF trial
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Effect of Valsartan on N-Terminal Pro-Brain Natriuretic Peptide in Patient With Stable Chronic Heart Failure: Comparison With Enalapril
por: Lee, Young Soo, et al.
Publicado: (2011)

The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction
por: Zhao, Ying, et al.
Publicado: (2022)

Sacubitril–valsartan versus enalapril for the treatment of acute decompensated heart failure in Chinese settings: A cost-effectiveness analysis
por: Hu, Tianyang, et al.
Publicado: (2023)

Cost-Effectiveness of Sacubitril/Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction: A Systematic Review
por: Rezapour, Aziz, et al.
Publicado: (2022)

Hospitalization and Mortality in Patients With Heart Failure Treated With Sacubitril/Valsartan vs. Enalapril: A Real-World, Population-Based Study
por: Pathadka, Swathi, et al.
Publicado: (2021)

Effects of Angiotensin Receptor-Neprilysin Inhibitors Versus Enalapril or Valsartan on Patients With Heart Failure: A Systematic Review and Meta-Analysis
por: Jain, Arpit, et al.
Publicado: (2023)

Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial
por: Vardeny, Orly, et al.
Publicado: (2016)

Losartan, but not Enalapril and Valsartan, Inhibits the Expression of IFN-γ, IL-6, IL-17F and IL-22 in PBMCs from Rheumatoid Arthritis Patients
por: Cardoso, Pablo R. G., et al.
Publicado: (2018)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

Efficacy and safety of sacubitril/valsartan compared with enalapril in patients with chronic heart failure and reduced ejection fraction: Results from PARADIGM-HF India sub-study
por: Jain, Anil Ranjeetmal, et al.
Publicado: (2020)

Hemodynamic and mitochondrial effects of enalapril in experimental sepsis
por: Pereira, AJ, et al.
Publicado: (2013)

Efficacy of Topical Enalapril in Treatment of Hypertrophic Scars
por: Mohammadi, Ali Akbar, et al.
Publicado: (2018)

Amlodipine/enalapril: Lack of efficacy: case report
Publicado: (2022)

Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
por: Anand, Inder S, et al.
Publicado: (2010)

Adherence and Persistence with Once-Daily vs Twice-Daily Direct Oral Anticoagulants Among Patients with Atrial Fibrillation: Real-World Analyses from the Netherlands, Italy and Germany
por: Smits, Elisabeth, et al.
Publicado: (2022)

Rationale and design of a multi‐center, prospective randomized controlled trial on the effects of sacubitril–valsartan versus enalapril on left ventricular remodeling in ST‐elevation myocardial infarction: The PERI‐STEMI study
por: Diao, Kaiyue, et al.
Publicado: (2021)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
por: Barrios, Vivencio, et al.
Publicado: (2008)

Formulation and Evaluation of Mucoadhesive Buccal Films of Enalapril Maleate
por: Semalty, A, et al.
Publicado: (2010)

Lercanidipine/enalapril combination in the management of obesity-related hypertension
por: Grassi, Guido
Publicado: (2016)

Impaired angiogenesis in the enalapril-treated neonatal rat kidney
por: Yim, Hyung Eun, et al.
Publicado: (2016)

Enalapril‐induced angioedema: A forgotten adverse event
por: Manzur‐Barbur, María Carolina, et al.
Publicado: (2022)

Bioconcentration of carbamazepine, enalapril, and sildenafil in neotropical fish species
por: Rojo, Macarena Gisele, et al.
Publicado: (2023)

Cardio-renal benefits of sacubitril/valsartan in patients with advanced chronic kidney disease: experience in daily clinical practice
por: Martínez-Esteban, María Dolores, et al.
Publicado: (2022)

Enalapril and Enalaprilat Pharmacokinetics in Children with Heart Failure Due to Dilated Cardiomyopathy and Congestive Heart Failure after Administration of an Orodispersible Enalapril Minitablet (LENA-Studies)
por: Laeer, Stephanie, et al.
Publicado: (2022)

Enalapril induced severe hyponatremia and altered sensorium in a child
por: Zaki, Syed Ahmed, et al.
Publicado: (2011)

Effect of Sacubitril-Valsartan on Restoration and Maintenance of Sinus Rhythm in Patients With Persistent Atrial Fibrillation
por: Chen, Qingsong, et al.
Publicado: (2022)

Individual or combined effects of enalapril and verapamil on chronic cyclosporine nephrotoxicity in rats.
por: Lee, S. K., et al.
Publicado: (1999)

Enalapril protects endothelial cells against induced apoptosis in Alzheimer's disease
por: Meamar, Rokhsareh, et al.
Publicado: (2013)

Effect of enalapril in cisplatin-induced nephrotoxicity in rats; gender-related difference
por: Zamani, Zohreh, et al.
Publicado: (2016)

Cardiac and Renal Effects of Atrasentan in Combination with Enalapril and Paricalcitol in Uremic Rats
por: Ritter, Cynthia, et al.
Publicado: (2014)

Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence
por: Antza, Christina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pnof35js4il8gu7qj888om369n